Softgel Healthcare Private Limited, established on October 23, 2003, is a privately held pharmaceutical company headquartered in Pudupakkam, Tamil Nadu, India. The company is registered under the Corporate Identification Number (CIN) U24231TN2003PTC051829 and is classified as a non-government company. As of the latest available data, Softgel Healthcare has an authorized share capital of ₹40 crore and a paid-up capital of ₹29.96 crore. The company's registered office is located at Survey No. 20/1, Vandalur – Kelambakkam Road, Pudupakkam Village, Chengalpattu District, Tamil Nadu, India – 603103.
Softgel Healthcare specializes in the manufacture of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, across various therapeutic categories. The company's product portfolio is concentrated, with the top five products accounting for 99.6% of its total export value. In the fiscal year 2022-2026, the company reported a total export value of $11.5 million USD from 238 shipments, exporting six products across four therapeutic categories. The top five products by export value are Vitamin ($6.8 million, 4.8% market share), Acetaminophen ($2.1 million, 0.9% market share), Dextromethorphan ($1.1 million, 7.4% market share), Phenylephrine ($1.1 million, 1.2% market share), and Omega ($316,000, 1.7% market share).
